Loading…

The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors

The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negati...

Full description

Saved in:
Bibliographic Details
Published in:PLoS computational biology 2018-01, Vol.14 (1), p.e1005948-e1005948
Main Authors: Verma, Ravi Kumar, Abramyan, Ara M, Michino, Mayako, Free, R Benjamin, Sibley, David R, Javitch, Jonathan A, Lane, J Robert, Shi, Lei
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3
cites cdi_FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3
container_end_page e1005948
container_issue 1
container_start_page e1005948
container_title PLoS computational biology
container_volume 14
creator Verma, Ravi Kumar
Abramyan, Ara M
Michino, Mayako
Free, R Benjamin
Sibley, David R
Javitch, Jonathan A
Lane, J Robert
Shi, Lei
description The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negative allosteric modulator. Previous studies identified Glu2.65 in the SBP to be a key determinant of both the affinity of SB269652 and the magnitude of its cooperativity with orthosteric ligands, as the E2.65A mutation decreased both of these parameters. However, the proposed hydrogen bond (H-bond) between Glu2.65 and the indole moiety of SB269652 is not a strong interaction, and a structure activity relationship study of SB269652 indicates that this H-bond may not be the only element that determines its allosteric properties. To understand the structural basis of the observed phenotype of E2.65A, we carried out molecular dynamics simulations with a cumulative length of ~77 μs of D2R and D3R wild-type and their E2.65A mutants bound to SB269652. In combination with Markov state model analysis and by characterizing the equilibria of ligand binding modes in different conditions, we found that in both D2R and D3R, whereas the tetrahydroisoquinoline moiety of SB269652 is stably bound in the OBS, the indole-2-carboxamide moiety is dynamic and only intermittently forms H-bonds with Glu2.65. Our results also indicate that the E2.65A mutation significantly affects the overall shape and size of the SBP, as well as the conformation of the N terminus. Thus, our findings suggest that the key role of Glu2.65 in mediating the allosteric properties of SB269652 extends beyond a direct interaction with SB269652, and provide structural insights for rational design of SB269652 derivatives that may retain its allosteric properties.
doi_str_mv 10.1371/journal.pcbi.1005948
format article
fullrecord <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2002623121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c32595f0cebf4f86b145258df520dd63</doaj_id><sourcerecordid>1989578006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3</originalsourceid><addsrcrecordid>eNptkktv1DAUhSMEog_4BwgssWEzgx-xE2-QSlugUiUWlLXlx_XUo4wd7KRS_z1uJ61axMpX198519c6TfOO4DVhHfm8TXOOeliP1oQ1wZjLtn_RHBLO2apjvH_5pD5ojkrZYlxLKV43B1Qy1sleHDbm6hrQOV0LfoJ286SnkCJyoeR5nApyt1HvgkUmRBfiBo2pQEHJo19fqZCCU6QnNFUHl8YKRkBntRUdOmMog4VxSrm8aV55PRR4u5zHze9v51enP1aXP79fnJ5crmxdp18JgZkz1mtuO6AAwB1vjew805JrA4T4imnLCBaOGOyJh653pOIeWmrYcfNh7zsOqajle4qiGFNBGaGkEhd7wiW9VWMOO51vVdJB3TdS3iidp2AHUJZRLrnHFoxvfS8MaTnlvfOcYucEq15flmmz2YGzEKesh2emz29iuFabdKN41wtGZDX4tBjk9GeGMqldKBaGQUdIc1FE9rKyGIuKfvwH_f927Z6yOZWSwT8-hmB1F5kHlbqLjFoiU2Xvny7yKHrICPsLZ8u9gg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2002623121</pqid></control><display><type>article</type><title>The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Verma, Ravi Kumar ; Abramyan, Ara M ; Michino, Mayako ; Free, R Benjamin ; Sibley, David R ; Javitch, Jonathan A ; Lane, J Robert ; Shi, Lei</creator><contributor>Jacobs, Donald</contributor><creatorcontrib>Verma, Ravi Kumar ; Abramyan, Ara M ; Michino, Mayako ; Free, R Benjamin ; Sibley, David R ; Javitch, Jonathan A ; Lane, J Robert ; Shi, Lei ; Jacobs, Donald</creatorcontrib><description>The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negative allosteric modulator. Previous studies identified Glu2.65 in the SBP to be a key determinant of both the affinity of SB269652 and the magnitude of its cooperativity with orthosteric ligands, as the E2.65A mutation decreased both of these parameters. However, the proposed hydrogen bond (H-bond) between Glu2.65 and the indole moiety of SB269652 is not a strong interaction, and a structure activity relationship study of SB269652 indicates that this H-bond may not be the only element that determines its allosteric properties. To understand the structural basis of the observed phenotype of E2.65A, we carried out molecular dynamics simulations with a cumulative length of ~77 μs of D2R and D3R wild-type and their E2.65A mutants bound to SB269652. In combination with Markov state model analysis and by characterizing the equilibria of ligand binding modes in different conditions, we found that in both D2R and D3R, whereas the tetrahydroisoquinoline moiety of SB269652 is stably bound in the OBS, the indole-2-carboxamide moiety is dynamic and only intermittently forms H-bonds with Glu2.65. Our results also indicate that the E2.65A mutation significantly affects the overall shape and size of the SBP, as well as the conformation of the N terminus. Thus, our findings suggest that the key role of Glu2.65 in mediating the allosteric properties of SB269652 extends beyond a direct interaction with SB269652, and provide structural insights for rational design of SB269652 derivatives that may retain its allosteric properties.</description><identifier>ISSN: 1553-7358</identifier><identifier>ISSN: 1553-734X</identifier><identifier>EISSN: 1553-7358</identifier><identifier>DOI: 10.1371/journal.pcbi.1005948</identifier><identifier>PMID: 29337986</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Allosteric properties ; Allosteric Regulation ; Allosteric Site ; Antipsychotics ; Bayes Theorem ; Binding sites ; Biology and Life Sciences ; Biophysics ; Chemical bonds ; Cluster Analysis ; Computational chemistry ; Computer Simulation ; Conformation ; Dopamine ; Dopamine D2 receptors ; Dopamine D3 receptors ; Drug abuse ; Humans ; Hydrogen Bonding ; Hydrogen bonds ; Indoles ; Indoles - chemistry ; Isoquinolines - chemistry ; Ligands ; Markov Chains ; Medicine and Health Sciences ; Molecular dynamics ; Molecular Dynamics Simulation ; Mutants ; Mutation ; Phenotype ; Phenotypes ; Physical Sciences ; Prescription drugs ; Properties (attributes) ; Protein Binding ; Protein Domains ; Protein Structure, Secondary ; Proteins ; Receptors ; Receptors, Dopamine D2 - chemistry ; Receptors, Dopamine D2 - genetics ; Receptors, Dopamine D3 - chemistry ; Receptors, Dopamine D3 - genetics ; Research and Analysis Methods ; Strong interactions (field theory) ; Structure-Activity Relationship ; Tetrahydroisoquinoline</subject><ispartof>PLoS computational biology, 2018-01, Vol.14 (1), p.e1005948-e1005948</ispartof><rights>2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors. PLoS Comput Biol 14(1): e1005948. https://doi.org/10.1371/journal.pcbi.1005948</rights><rights>2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors. PLoS Comput Biol 14(1): e1005948. https://doi.org/10.1371/journal.pcbi.1005948</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3</citedby><cites>FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3</cites><orcidid>0000-0002-4137-096X ; 0000-0002-7361-7875 ; 0000-0002-2428-0487</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2002623121/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2002623121?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29337986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Jacobs, Donald</contributor><creatorcontrib>Verma, Ravi Kumar</creatorcontrib><creatorcontrib>Abramyan, Ara M</creatorcontrib><creatorcontrib>Michino, Mayako</creatorcontrib><creatorcontrib>Free, R Benjamin</creatorcontrib><creatorcontrib>Sibley, David R</creatorcontrib><creatorcontrib>Javitch, Jonathan A</creatorcontrib><creatorcontrib>Lane, J Robert</creatorcontrib><creatorcontrib>Shi, Lei</creatorcontrib><title>The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors</title><title>PLoS computational biology</title><addtitle>PLoS Comput Biol</addtitle><description>The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negative allosteric modulator. Previous studies identified Glu2.65 in the SBP to be a key determinant of both the affinity of SB269652 and the magnitude of its cooperativity with orthosteric ligands, as the E2.65A mutation decreased both of these parameters. However, the proposed hydrogen bond (H-bond) between Glu2.65 and the indole moiety of SB269652 is not a strong interaction, and a structure activity relationship study of SB269652 indicates that this H-bond may not be the only element that determines its allosteric properties. To understand the structural basis of the observed phenotype of E2.65A, we carried out molecular dynamics simulations with a cumulative length of ~77 μs of D2R and D3R wild-type and their E2.65A mutants bound to SB269652. In combination with Markov state model analysis and by characterizing the equilibria of ligand binding modes in different conditions, we found that in both D2R and D3R, whereas the tetrahydroisoquinoline moiety of SB269652 is stably bound in the OBS, the indole-2-carboxamide moiety is dynamic and only intermittently forms H-bonds with Glu2.65. Our results also indicate that the E2.65A mutation significantly affects the overall shape and size of the SBP, as well as the conformation of the N terminus. Thus, our findings suggest that the key role of Glu2.65 in mediating the allosteric properties of SB269652 extends beyond a direct interaction with SB269652, and provide structural insights for rational design of SB269652 derivatives that may retain its allosteric properties.</description><subject>Allosteric properties</subject><subject>Allosteric Regulation</subject><subject>Allosteric Site</subject><subject>Antipsychotics</subject><subject>Bayes Theorem</subject><subject>Binding sites</subject><subject>Biology and Life Sciences</subject><subject>Biophysics</subject><subject>Chemical bonds</subject><subject>Cluster Analysis</subject><subject>Computational chemistry</subject><subject>Computer Simulation</subject><subject>Conformation</subject><subject>Dopamine</subject><subject>Dopamine D2 receptors</subject><subject>Dopamine D3 receptors</subject><subject>Drug abuse</subject><subject>Humans</subject><subject>Hydrogen Bonding</subject><subject>Hydrogen bonds</subject><subject>Indoles</subject><subject>Indoles - chemistry</subject><subject>Isoquinolines - chemistry</subject><subject>Ligands</subject><subject>Markov Chains</subject><subject>Medicine and Health Sciences</subject><subject>Molecular dynamics</subject><subject>Molecular Dynamics Simulation</subject><subject>Mutants</subject><subject>Mutation</subject><subject>Phenotype</subject><subject>Phenotypes</subject><subject>Physical Sciences</subject><subject>Prescription drugs</subject><subject>Properties (attributes)</subject><subject>Protein Binding</subject><subject>Protein Domains</subject><subject>Protein Structure, Secondary</subject><subject>Proteins</subject><subject>Receptors</subject><subject>Receptors, Dopamine D2 - chemistry</subject><subject>Receptors, Dopamine D2 - genetics</subject><subject>Receptors, Dopamine D3 - chemistry</subject><subject>Receptors, Dopamine D3 - genetics</subject><subject>Research and Analysis Methods</subject><subject>Strong interactions (field theory)</subject><subject>Structure-Activity Relationship</subject><subject>Tetrahydroisoquinoline</subject><issn>1553-7358</issn><issn>1553-734X</issn><issn>1553-7358</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkktv1DAUhSMEog_4BwgssWEzgx-xE2-QSlugUiUWlLXlx_XUo4wd7KRS_z1uJ61axMpX198519c6TfOO4DVhHfm8TXOOeliP1oQ1wZjLtn_RHBLO2apjvH_5pD5ojkrZYlxLKV43B1Qy1sleHDbm6hrQOV0LfoJ286SnkCJyoeR5nApyt1HvgkUmRBfiBo2pQEHJo19fqZCCU6QnNFUHl8YKRkBntRUdOmMog4VxSrm8aV55PRR4u5zHze9v51enP1aXP79fnJ5crmxdp18JgZkz1mtuO6AAwB1vjew805JrA4T4imnLCBaOGOyJh653pOIeWmrYcfNh7zsOqajle4qiGFNBGaGkEhd7wiW9VWMOO51vVdJB3TdS3iidp2AHUJZRLrnHFoxvfS8MaTnlvfOcYucEq15flmmz2YGzEKesh2emz29iuFabdKN41wtGZDX4tBjk9GeGMqldKBaGQUdIc1FE9rKyGIuKfvwH_f927Z6yOZWSwT8-hmB1F5kHlbqLjFoiU2Xvny7yKHrICPsLZ8u9gg</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Verma, Ravi Kumar</creator><creator>Abramyan, Ara M</creator><creator>Michino, Mayako</creator><creator>Free, R Benjamin</creator><creator>Sibley, David R</creator><creator>Javitch, Jonathan A</creator><creator>Lane, J Robert</creator><creator>Shi, Lei</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AL</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0N</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4137-096X</orcidid><orcidid>https://orcid.org/0000-0002-7361-7875</orcidid><orcidid>https://orcid.org/0000-0002-2428-0487</orcidid></search><sort><creationdate>201801</creationdate><title>The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors</title><author>Verma, Ravi Kumar ; Abramyan, Ara M ; Michino, Mayako ; Free, R Benjamin ; Sibley, David R ; Javitch, Jonathan A ; Lane, J Robert ; Shi, Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Allosteric properties</topic><topic>Allosteric Regulation</topic><topic>Allosteric Site</topic><topic>Antipsychotics</topic><topic>Bayes Theorem</topic><topic>Binding sites</topic><topic>Biology and Life Sciences</topic><topic>Biophysics</topic><topic>Chemical bonds</topic><topic>Cluster Analysis</topic><topic>Computational chemistry</topic><topic>Computer Simulation</topic><topic>Conformation</topic><topic>Dopamine</topic><topic>Dopamine D2 receptors</topic><topic>Dopamine D3 receptors</topic><topic>Drug abuse</topic><topic>Humans</topic><topic>Hydrogen Bonding</topic><topic>Hydrogen bonds</topic><topic>Indoles</topic><topic>Indoles - chemistry</topic><topic>Isoquinolines - chemistry</topic><topic>Ligands</topic><topic>Markov Chains</topic><topic>Medicine and Health Sciences</topic><topic>Molecular dynamics</topic><topic>Molecular Dynamics Simulation</topic><topic>Mutants</topic><topic>Mutation</topic><topic>Phenotype</topic><topic>Phenotypes</topic><topic>Physical Sciences</topic><topic>Prescription drugs</topic><topic>Properties (attributes)</topic><topic>Protein Binding</topic><topic>Protein Domains</topic><topic>Protein Structure, Secondary</topic><topic>Proteins</topic><topic>Receptors</topic><topic>Receptors, Dopamine D2 - chemistry</topic><topic>Receptors, Dopamine D2 - genetics</topic><topic>Receptors, Dopamine D3 - chemistry</topic><topic>Receptors, Dopamine D3 - genetics</topic><topic>Research and Analysis Methods</topic><topic>Strong interactions (field theory)</topic><topic>Structure-Activity Relationship</topic><topic>Tetrahydroisoquinoline</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Verma, Ravi Kumar</creatorcontrib><creatorcontrib>Abramyan, Ara M</creatorcontrib><creatorcontrib>Michino, Mayako</creatorcontrib><creatorcontrib>Free, R Benjamin</creatorcontrib><creatorcontrib>Sibley, David R</creatorcontrib><creatorcontrib>Javitch, Jonathan A</creatorcontrib><creatorcontrib>Lane, J Robert</creatorcontrib><creatorcontrib>Shi, Lei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Computing Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Computing Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS computational biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Verma, Ravi Kumar</au><au>Abramyan, Ara M</au><au>Michino, Mayako</au><au>Free, R Benjamin</au><au>Sibley, David R</au><au>Javitch, Jonathan A</au><au>Lane, J Robert</au><au>Shi, Lei</au><au>Jacobs, Donald</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors</atitle><jtitle>PLoS computational biology</jtitle><addtitle>PLoS Comput Biol</addtitle><date>2018-01</date><risdate>2018</risdate><volume>14</volume><issue>1</issue><spage>e1005948</spage><epage>e1005948</epage><pages>e1005948-e1005948</pages><issn>1553-7358</issn><issn>1553-734X</issn><eissn>1553-7358</eissn><abstract>The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negative allosteric modulator. Previous studies identified Glu2.65 in the SBP to be a key determinant of both the affinity of SB269652 and the magnitude of its cooperativity with orthosteric ligands, as the E2.65A mutation decreased both of these parameters. However, the proposed hydrogen bond (H-bond) between Glu2.65 and the indole moiety of SB269652 is not a strong interaction, and a structure activity relationship study of SB269652 indicates that this H-bond may not be the only element that determines its allosteric properties. To understand the structural basis of the observed phenotype of E2.65A, we carried out molecular dynamics simulations with a cumulative length of ~77 μs of D2R and D3R wild-type and their E2.65A mutants bound to SB269652. In combination with Markov state model analysis and by characterizing the equilibria of ligand binding modes in different conditions, we found that in both D2R and D3R, whereas the tetrahydroisoquinoline moiety of SB269652 is stably bound in the OBS, the indole-2-carboxamide moiety is dynamic and only intermittently forms H-bonds with Glu2.65. Our results also indicate that the E2.65A mutation significantly affects the overall shape and size of the SBP, as well as the conformation of the N terminus. Thus, our findings suggest that the key role of Glu2.65 in mediating the allosteric properties of SB269652 extends beyond a direct interaction with SB269652, and provide structural insights for rational design of SB269652 derivatives that may retain its allosteric properties.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>29337986</pmid><doi>10.1371/journal.pcbi.1005948</doi><orcidid>https://orcid.org/0000-0002-4137-096X</orcidid><orcidid>https://orcid.org/0000-0002-7361-7875</orcidid><orcidid>https://orcid.org/0000-0002-2428-0487</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1553-7358
ispartof PLoS computational biology, 2018-01, Vol.14 (1), p.e1005948-e1005948
issn 1553-7358
1553-734X
1553-7358
language eng
recordid cdi_plos_journals_2002623121
source Open Access: PubMed Central; Publicly Available Content Database (Proquest) (PQ_SDU_P3)
subjects Allosteric properties
Allosteric Regulation
Allosteric Site
Antipsychotics
Bayes Theorem
Binding sites
Biology and Life Sciences
Biophysics
Chemical bonds
Cluster Analysis
Computational chemistry
Computer Simulation
Conformation
Dopamine
Dopamine D2 receptors
Dopamine D3 receptors
Drug abuse
Humans
Hydrogen Bonding
Hydrogen bonds
Indoles
Indoles - chemistry
Isoquinolines - chemistry
Ligands
Markov Chains
Medicine and Health Sciences
Molecular dynamics
Molecular Dynamics Simulation
Mutants
Mutation
Phenotype
Phenotypes
Physical Sciences
Prescription drugs
Properties (attributes)
Protein Binding
Protein Domains
Protein Structure, Secondary
Proteins
Receptors
Receptors, Dopamine D2 - chemistry
Receptors, Dopamine D2 - genetics
Receptors, Dopamine D3 - chemistry
Receptors, Dopamine D3 - genetics
Research and Analysis Methods
Strong interactions (field theory)
Structure-Activity Relationship
Tetrahydroisoquinoline
title The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A45%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20E2.65A%20mutation%20disrupts%20dynamic%20binding%20poses%20of%20SB269652%20at%20the%20dopamine%20D2%20and%20D3%20receptors&rft.jtitle=PLoS%20computational%20biology&rft.au=Verma,%20Ravi%20Kumar&rft.date=2018-01&rft.volume=14&rft.issue=1&rft.spage=e1005948&rft.epage=e1005948&rft.pages=e1005948-e1005948&rft.issn=1553-7358&rft.eissn=1553-7358&rft_id=info:doi/10.1371/journal.pcbi.1005948&rft_dat=%3Cproquest_plos_%3E1989578006%3C/proquest_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2002623121&rft_id=info:pmid/29337986&rfr_iscdi=true